TW218353B - - Google Patents
Info
- Publication number
- TW218353B TW218353B TW079108866A TW79108866A TW218353B TW 218353 B TW218353 B TW 218353B TW 079108866 A TW079108866 A TW 079108866A TW 79108866 A TW79108866 A TW 79108866A TW 218353 B TW218353 B TW 218353B
- Authority
- TW
- Taiwan
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27021589 | 1989-10-19 | ||
JP02241192A JP3087293B2 (ja) | 1990-09-13 | 1990-09-13 | 糖応答型高分子複合体 |
JP2241191A JP2874309B2 (ja) | 1990-09-13 | 1990-09-13 | 糖応答性高分子複合体 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW218353B true TW218353B (zh) | 1994-01-01 |
Family
ID=27332917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW079108866A TW218353B (zh) | 1989-10-19 | 1990-10-19 |
Country Status (8)
Country | Link |
---|---|
US (1) | US5478575A (zh) |
EP (1) | EP0424168B1 (zh) |
KR (1) | KR930001305B1 (zh) |
AU (1) | AU628674B2 (zh) |
CA (1) | CA2027930C (zh) |
DE (1) | DE69003068T2 (zh) |
DK (1) | DK0424168T3 (zh) |
TW (1) | TW218353B (zh) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997037680A1 (en) * | 1996-04-05 | 1997-10-16 | The Board Of Trustees Of The University Of Illinois | Macromolecular complexes for drug delivery |
US5935599A (en) * | 1996-10-28 | 1999-08-10 | The Board Of Trustees Of The University Of Illinois | Polymer-associated liposomes for drug delivery and method of manufacturing the same |
US7316999B2 (en) * | 2000-06-02 | 2008-01-08 | Novo Nordisk A/S | Glucose dependent release of insulin from glucose sensing insulin derivatives |
AU2001263775A1 (en) * | 2000-06-02 | 2001-12-11 | Novo-Nordisk A/S | Glucose dependent release of insulin from glucose sensing insulin derivatives |
US6417237B1 (en) | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
KR100431536B1 (ko) * | 2001-02-14 | 2004-05-20 | 박상규 | pH변화를 이용한 식품 품질 식별표시계 |
JP5052736B2 (ja) * | 2001-05-30 | 2012-10-17 | 中外製薬株式会社 | タンパク質製剤 |
AU2002349295A1 (en) * | 2001-12-02 | 2003-06-17 | Novo Nordisk A/S | Glucose dependant release of insulin from glucose sensing insulin derivatives |
US7317000B2 (en) | 2001-12-02 | 2008-01-08 | Novo Nordisk A/S | Glucose-dependent insulins |
GB0305587D0 (en) * | 2003-03-11 | 2003-04-16 | Smart Holograms Ltd | Sensor |
CA2575431A1 (en) * | 2004-07-30 | 2006-02-02 | Basf Ag | Polymeric boronic acid derivatives and their use for papermaking |
CA2507121A1 (en) * | 2005-05-12 | 2006-11-12 | Le Groupe Lysac Inc. | Galactomannan hydrophobic complexes as superabsorbent polymers |
GB0519169D0 (en) * | 2005-09-21 | 2005-10-26 | Leuven K U Res & Dev | Novel anti-viral strategy |
ES2553154T3 (es) * | 2006-05-09 | 2015-12-04 | Novo Nordisk A/S | Derivado de la insulina |
JP5550338B2 (ja) * | 2006-07-31 | 2014-07-16 | ノボ・ノルデイスク・エー/エス | ペグ化持続型インスリン |
CN101541830A (zh) * | 2006-09-22 | 2009-09-23 | 诺沃-诺迪斯克有限公司 | 蛋白酶抗性的胰岛素类似物 |
ES2563038T3 (es) * | 2007-04-30 | 2016-03-10 | Novo Nordisk A/S | Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca |
JP5675347B2 (ja) * | 2007-06-01 | 2015-02-25 | ノボ・ノルデイスク・エー/エス | 安定した非水性薬学的組成物 |
ES2618073T3 (es) * | 2008-03-14 | 2017-06-20 | Novo Nordisk A/S | Análogos de insulina estabilizados frente a proteasas |
EP2910571B1 (en) | 2008-03-18 | 2016-10-05 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
AU2010208381A1 (en) | 2009-01-28 | 2011-08-04 | Smartcells, Inc. | Exogenously triggered controlled release materials and uses thereof |
SG173117A1 (en) | 2009-01-28 | 2011-08-29 | Smartcells Inc | Crystalline insulin-conjugates |
WO2010088286A1 (en) | 2009-01-28 | 2010-08-05 | Smartcells, Inc. | Synthetic conjugates and uses thereof |
MA33064B1 (fr) | 2009-01-28 | 2012-02-01 | Smartcells Inc | Systemes à base de conjugués pour administration contrôlée de médicaments |
WO2010107519A1 (en) | 2009-03-20 | 2010-09-23 | Smartcells, Inc. | Terminally-functionalized conjugates and uses thereof |
EP2408470A4 (en) | 2009-03-20 | 2012-08-29 | Smartcells Inc | SOLUBLE NONDEPOT INSULIN CONJUGATE AND ITS USE |
WO2011000823A1 (en) | 2009-06-30 | 2011-01-06 | Novo Nordisk A/S | Insulin derivatives |
EP2582741B1 (en) | 2010-06-18 | 2016-07-27 | Universiteit Twente | Boronated polymers |
JP2013541500A (ja) | 2010-07-28 | 2013-11-14 | スマートセルズ・インコーポレイテツド | 組換えレクチン、結合部位修飾レクチンおよびそれらの用途 |
WO2012015692A2 (en) | 2010-07-28 | 2012-02-02 | Smartcells, Inc. | Recombinantly expressed insulin polypeptides and uses thereof |
US8933207B2 (en) | 2010-07-28 | 2015-01-13 | Smartcells, Inc. | Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
CA2870313A1 (en) | 2012-04-11 | 2013-10-17 | Novo Nordisk A/S | Insulin formulations |
WO2013168136A1 (en) * | 2012-05-11 | 2013-11-14 | Schlumberger Technology B.V. | Thickening of fluids |
JP6364067B2 (ja) | 2013-04-05 | 2018-07-25 | ノボ・ノルデイスク・エー/エス | 薬剤送達装置の投与記録装置 |
MX366852B (es) | 2013-10-04 | 2019-07-25 | Merck Sharp & Dohme | Conjugados de insulina sensibles a glucosa. |
WO2015052088A1 (en) | 2013-10-07 | 2015-04-16 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
CN105153347B (zh) * | 2015-08-11 | 2017-07-07 | 台州学院 | 糖响应的单分散聚合物空心微球的制备方法 |
EP3393641B1 (en) * | 2015-12-22 | 2020-04-29 | DDP Specialty Electronic Materials US 8, LLC | Method of suspension polymerization of droplets distributed in an aqueous medium |
MX2019006463A (es) | 2016-12-16 | 2019-08-14 | Novo Nordisk As | Composiciones farmaceuticas que contienen insulina. |
WO2018223114A1 (en) * | 2017-06-02 | 2018-12-06 | North Carolina State University | Glucose sensitive compositions for drug delivery |
CN107556509B (zh) * | 2017-08-28 | 2020-07-14 | 上海第二工业大学 | 一种二维光子晶体葡萄糖传感薄膜的制备方法 |
JP7254792B2 (ja) | 2017-11-09 | 2023-04-10 | ノヴォ ノルディスク アー/エス | グルコース感受性アルブミン結合誘導体 |
CN108102004B (zh) * | 2018-01-03 | 2020-02-14 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 一种葡聚糖聚合物、聚合物胶束和药物载体系统 |
CN110452390B (zh) * | 2018-05-03 | 2021-04-06 | 清华大学深圳研究生院 | 一种胰岛素智能给药制剂 |
EP3586876A1 (en) | 2018-06-21 | 2020-01-01 | Gubra ApS | Glucose-sensitive peptide hormones |
TW202112397A (zh) * | 2019-03-29 | 2021-04-01 | 丹麥商諾佛.儂迪克股份有限公司 | 葡萄糖敏感型胰島素衍生物 |
CN110483691B (zh) * | 2019-09-25 | 2021-11-09 | 安徽大学 | 一种三元共聚物交联剂及其在扩散渗析专用阳离子膜制备中的应用 |
CN115975224B (zh) * | 2023-03-16 | 2023-08-08 | 四川大学 | 一种pH/ROS双响应的组织粘附载药水凝胶及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0110879A1 (en) * | 1982-05-26 | 1984-06-20 | The Children's Medical Center Corporation | Reporter compounds |
IT1173459B (it) * | 1984-03-22 | 1987-06-24 | Sirac Spa | Resine boroniche stabili ad elevato potere assorbente selettivo |
IT1215406B (it) * | 1987-04-03 | 1990-02-08 | Sirac Spa | Resine boroniche stabili di elevato poytere assorbente selettivo. |
IT1215407B (it) * | 1987-04-03 | 1990-02-08 | Sirac Spa | Resine boroniche di elevato potere assorbente selettivo. |
-
1990
- 1990-10-18 CA CA002027930A patent/CA2027930C/en not_active Expired - Fee Related
- 1990-10-18 AU AU64754/90A patent/AU628674B2/en not_active Ceased
- 1990-10-18 KR KR1019900016644A patent/KR930001305B1/ko not_active IP Right Cessation
- 1990-10-19 EP EP90311485A patent/EP0424168B1/en not_active Expired - Lifetime
- 1990-10-19 DK DK90311485.8T patent/DK0424168T3/da active
- 1990-10-19 DE DE90311485T patent/DE69003068T2/de not_active Expired - Fee Related
- 1990-10-19 TW TW079108866A patent/TW218353B/zh active
-
1993
- 1993-03-26 US US08/037,383 patent/US5478575A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5478575A (en) | 1995-12-26 |
DE69003068D1 (de) | 1993-10-07 |
AU6475490A (en) | 1991-07-11 |
EP0424168A1 (en) | 1991-04-24 |
KR910007545A (ko) | 1991-05-30 |
DE69003068T2 (de) | 1993-12-16 |
CA2027930A1 (en) | 1991-04-20 |
EP0424168B1 (en) | 1993-09-01 |
DK0424168T3 (da) | 1993-12-13 |
KR930001305B1 (ko) | 1993-02-25 |
AU628674B2 (en) | 1992-09-17 |
CA2027930C (en) | 1998-06-30 |